Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProF-001 vs Fluconazole in Recurrent Vulvovaginal Candidiasis
NCT04734405Phase 3Unknown
- Sponsor
- ProFem
- Start
- Oct 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of Candiplus in recurrent vulvovaginal candidiasis (RVVC), sponsored by ProFem. Status: unknown.
02
Drugs
Candiplus
03
Conditions
recurrent vulvovaginal candidiasis (RVVC)
Beyond the preview
Go deeper on NCT04734405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734405.